Causes of Early Mortality After Catheter Ablation of Atrial Fibrillation
BACKGROUND: Recognition of the causes of early mortality after atrial fibrillation (AF) catheter ablation is essential for the improvement of patient safety. This study sought to determine the causes of early mortality (≤90 days) after AF ablation.
METHODS: We performed a retrospective analysis of AF ablation from January 1, 2013, to December 1, 2021 at the Mayo Clinic (Rochester, Phoenix, and Jacksonville). Causes of death were identified through a comprehensive chart review of the electronic health record from within the Mayo Clinic system and outside records when available.
RESULTS: A total of 6723 patients were included in the study. The 90-day all-cause mortality rate was 0.22% (n=15). Among all 90-day deaths, majority of the deaths (73.3%) did not have a direct relationship with the procedure. Sudden death was the most common cause of early death (20%), followed by peri-procedural stroke (13%), respiratory failure (13%), atrioesophageal fistula (13%), infection (7%), heart failure (7%), and traumatic brain injury (7%). The 90-day mortality rate directly due to AF ablation procedural complications was 0.06% (n=4).
CONCLUSIONS: AF ablation procedure has a 90-day mortality of 0.22%, and the most common cause of early mortality was sudden death. The majority (73.3%) of early mortality was not directly associated with a procedural complication, and the mortality rate due to complications associated with the AF ablation procedure was low at 0.06%. Further studies are required to investigate causes and risk factors associated with sudden death in this patient population.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Circulation. Arrhythmia and electrophysiology - 16(2023), 5 vom: 01. Mai, Seite e011365 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tan, Min Choon [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Atrial fibrillation |
|---|
| Anmerkungen: |
Date Completed 18.05.2023 Date Revised 23.05.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1161/CIRCEP.122.011365 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM355867400 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM355867400 | ||
| 003 | DE-627 | ||
| 005 | 20231226065245.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/CIRCEP.122.011365 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1186.xml |
| 035 | |a (DE-627)NLM355867400 | ||
| 035 | |a (NLM)37082954 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tan, Min Choon |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Causes of Early Mortality After Catheter Ablation of Atrial Fibrillation |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.05.2023 | ||
| 500 | |a Date Revised 23.05.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: Recognition of the causes of early mortality after atrial fibrillation (AF) catheter ablation is essential for the improvement of patient safety. This study sought to determine the causes of early mortality (≤90 days) after AF ablation | ||
| 520 | |a METHODS: We performed a retrospective analysis of AF ablation from January 1, 2013, to December 1, 2021 at the Mayo Clinic (Rochester, Phoenix, and Jacksonville). Causes of death were identified through a comprehensive chart review of the electronic health record from within the Mayo Clinic system and outside records when available | ||
| 520 | |a RESULTS: A total of 6723 patients were included in the study. The 90-day all-cause mortality rate was 0.22% (n=15). Among all 90-day deaths, majority of the deaths (73.3%) did not have a direct relationship with the procedure. Sudden death was the most common cause of early death (20%), followed by peri-procedural stroke (13%), respiratory failure (13%), atrioesophageal fistula (13%), infection (7%), heart failure (7%), and traumatic brain injury (7%). The 90-day mortality rate directly due to AF ablation procedural complications was 0.06% (n=4) | ||
| 520 | |a CONCLUSIONS: AF ablation procedure has a 90-day mortality of 0.22%, and the most common cause of early mortality was sudden death. The majority (73.3%) of early mortality was not directly associated with a procedural complication, and the mortality rate due to complications associated with the AF ablation procedure was low at 0.06%. Further studies are required to investigate causes and risk factors associated with sudden death in this patient population | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a atrial fibrillation | |
| 650 | 4 | |a catheter ablation | |
| 650 | 4 | |a mortality | |
| 650 | 4 | |a outcome assessments | |
| 700 | 1 | |a Rattanawong, Pattara |e verfasserin |4 aut | |
| 700 | 1 | |a Karikalan, Suganya |e verfasserin |4 aut | |
| 700 | 1 | |a Deshmukh, Abhishek J |e verfasserin |4 aut | |
| 700 | 1 | |a Srivathsan, Komandoor |e verfasserin |4 aut | |
| 700 | 1 | |a Scott, Luis R |e verfasserin |4 aut | |
| 700 | 1 | |a McLeod, Christopher J |e verfasserin |4 aut | |
| 700 | 1 | |a Asirvatham, Samuel J |e verfasserin |4 aut | |
| 700 | 1 | |a Noseworthy, Peter A |e verfasserin |4 aut | |
| 700 | 1 | |a Mulpuru, Siva K |e verfasserin |4 aut | |
| 700 | 1 | |a Cha, Yong-Mei |e verfasserin |4 aut | |
| 700 | 1 | |a Munger, Thomas M |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Justin Z |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Circulation. Arrhythmia and electrophysiology |d 2008 |g 16(2023), 5 vom: 01. Mai, Seite e011365 |w (DE-627)NLM184814200 |x 1941-3084 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2023 |g number:5 |g day:01 |g month:05 |g pages:e011365 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1161/CIRCEP.122.011365 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2023 |e 5 |b 01 |c 05 |h e011365 | ||